SRRA - Sierra Oncology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 1.29
52-Week Change 3-69.88%
S&P500 52-Week Change 326.18%
52 Week High 32.0100
52 Week Low 30.2160
50-Day Moving Average 30.3850
200-Day Moving Average 30.3981

Share Statistics

Avg Vol (3 month) 32.22M
Avg Vol (10 day) 33.07M
Shares Outstanding 574.69M
Float 60.55M
% Held by Insiders 11.07%
% Held by Institutions 151.64%
Shares Short (Dec 30, 2019) 45.51M
Short Ratio (Dec 30, 2019) 41.51
Short % of Float (Dec 30, 2019) 48.39%
Short % of Shares Outstanding (Dec 30, 2019) 47.38%
Shares Short (prior month Nov 28, 2019) 43.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.86%
Return on Equity (ttm)-66.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -56.51M
Net Income Avi to Common (ttm)-55.1M
Diluted EPS (ttm)-0.7390
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.69M
Total Cash Per Share (mrq)0.91
Total Debt (mrq)5.61M
Total Debt/Equity (mrq)9.53
Current Ratio (mrq)7.69
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-48.7M
Levered Free Cash Flow (ttm)-29.39M